Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,569.09
(
0.37%
)
News Focus
News Focus

Replies to post #109590 on Biotech Values

Replies to #109590 on Biotech Values
icon url

DewDiligence

11/29/10 2:32 PM

#109595 RE: biomaven0 #109590

When you strip out the buzzwords, an RDT is a mediocre design that companies fall back on when they don’t know how to enrich a phase-2 trial with a biomarker.